AndreaBozzo/ceres-open-data-index huggingface dataset:
NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified)

NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified) - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf 
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus

NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus – 2020.  In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Prior to 2015, CDC's National Notifiable Diseases Surveillance System (NNDSS) did not receive electronic data about incident cases of specific viral hemorrhagic fevers; instead data were collected in aggregate as "viral hemorrhagic fevers". NNDSS was updated beginning in 2015 to receive data for each of the viral hemorrhagic fevers listed.
Patent AT-E401289-T1: [Translated] METHOD FOR SEPARATING POLAR IMPURITIES FROM AROMATIC CHARGES

Chemical patent from PubChem database. Patent Number: AT-E401289-T1. Title: Novel Chemical Entity. Filing Date: 1992-02-17. Inventors: Rodriguez, Juan, White, Jennifer. Abstract: The invention relates to a novel chemical entity with unique structural features and biological properties, suitable for development as a therapeutic ... IPC Classifications: C07H, A61K, A61P. This patent covers 38 claims related to 3 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Risk and Protective Factors Tables (Standard Errors and P Values) - 3.1 to 3.25

These detailed tables present standard errors for totals and prevalence estimates of risk and protective factors regarding substance use from the 2011 National Survey on Drug Use and Health (NSDUH). The factors include perceptions of 1) risk of substance use, 2) availability of substances, 3) parental disapproval of youth substance use, 4) peer substance use. These factors include measures of delinquent behavior, religious involvement, exposure to prevention messages, and parental involvement. Standard errors are provided by age group, gender, race/ethnicity, geographic area, and youth substance use behavior. Standard errors are provided for both 2011 and 2010.
Compound 525448: 3-Methyl-2,4-dithiahexane

Chemical compound data from PubChem database. IUPAC Name: 1-ethylsulfanyl-1-methylsulfanylethane. Molecular Formula: C5H12S2. Molecular Weight: 136.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Colorado: 2011-2012 NSDUH

This report presents Colorado\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 525352: 2,2-Dimethyl-3-thiaoctane

Chemical compound data from PubChem database. IUPAC Name: 1-tert-butylsulfanylpentane. Molecular Formula: C9H20S. Molecular Weight: 160.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526194: Disulfide, 1-propenyl 1-(1-propenylthio)propyl

Chemical compound data from PubChem database. IUPAC Name: 1-(prop-1-enyldisulfanyl)-1-prop-1-enylsulfanylpropane. Molecular Formula: C9H16S3. Molecular Weight: 220.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530579: 2,6-Difluorobenzoic acid, pentadecyl ester

Chemical compound data from PubChem database. IUPAC Name: pentadecyl 2,6-difluorobenzoate. Molecular Formula: C22H34F2O2. Molecular Weight: 368.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525492: 5,6-Dimethyl-4-thia-1-heptene

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-prop-2-enylsulfanylbutane. Molecular Formula: C8H16S. Molecular Weight: 144.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401590-T1: [Translated] COMPACT LENS WITH TWO POSITIVE INDIVIDUAL LENSES

It is to provide an imaging lens that can sufficiently handle the demands for reduction in size and weight and further improvement in the optical performance, e.g. for mobile phones or the like. The imaging lens comprises, in order from the object towards the image (7), a diaphragm (2), a first lens (3) which is a meniscus lens having positive power, the convex surface of which faces the object side, and a second lens (4) which is a lens having positive power, the convex surface of which faces the image (7), wherein conditions expressed by each of following inequalities (1)-(6) are to be satisfied; n1.25¥L/fl¥0.8, 0.55¥f 1 /f 2 >0, 1.5¥f 1 /fl¥0.9, 1¥d 2 /d 1 ¥0.2, 0.35¥d 1 /fl¥0.1, and 0.27¥d 3 /fl¥0.1 (where, L: entire length of the lens, fl: focal distance of the entire imaging lens, f 1 : focal distance of the first lens, f 2 : focal distance of the second lens, d 1 : center thickness of the first lens, d 2 : space between the first lens and the second lens on the optical axis, and d 3 : center thickness of the second lens).
Interaction of neuronal nitric oxide synthase with alpha

Background
          The C-terminal four amino acids (GEEV) of human α1A-adrenergic receptors (ARs) have been reported to interact with the PDZ domain of neuronal nitric oxide synthase (nNOS) in a yeast two-hybrid system. The other two α1-AR subtypes have no sequence homology in this region, raising the possibility of subtype-specific protein-protein interactions.
        
        
          Results
          We used co-immunoprecipitation and functional approaches with epitope-tagged α1-ARs to examine this interaction and the importance of the C-terminal tail. Following co-transfection of HEK-293 cells with hexahistidine/Flag (HF)-tagged α1A-ARs and nNOS, membranes were solubilized and immunoprecipitated with anti-FLAG affinity resin or anti-nNOS antibodies. Immunoprecipitation of HFα1A-ARs resulted in co-immunoprecipitation of nNOS and vice versa, confirming that these proteins interact. However, nNOS also co-immunoprecipitated with HFα1B- and HFα1D-ARs, suggesting that the interaction is not specific to the α1A subtype. In addition, nNOS co-immunoprecipitated with each of the three HFα1-AR subtypes which had been C-terminally truncated, suggesting that this interaction does not require the C-tails; and with Flag-tagged β1- and β2-ARs. Treatment of PC12 cells expressing HFα1A-ARs with an inhibitor of nitric oxide formation did not alter norepinephrine-mediated activation of mitogen activated protein kinases, suggesting nNOS is not involved in this response.
        
        
          Conclusions
          These results show that nNOS does interact with full-length α1A-ARs, but that this interaction is not subtype-specific and does not require the C-terminal tail, raising questions about its functional significance.
Compound 526269: 1,3,4,8-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,4,8-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526770: 11-Hydroxy-arachidic, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 11-[tert-butyl(dimethyl)silyl]oxyicosanoate. Molecular Formula: C27H56O3Si. Molecular Weight: 456.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527854: 2,4-Dichlorobenzyl undecyl ether

Chemical compound data from PubChem database. IUPAC Name: 2,4-dichloro-1-(undecoxymethyl)benzene. Molecular Formula: C18H28Cl2O. Molecular Weight: 331.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Staffed Family Child Care Networks: A Research-Informed Strategy for Supporting High-Quality Family Child Care

This brief includes a description of family child care (FCC) networks. It also outlines a well-informed strategy for supporting high-quality family child care:

Addresses the support a staff FCC network can provide Outlines the essential elements of an effective network Illustrates the value networks bring to the FCC profession

You may also be interested in these publications:

Developing a Staffed Family Child Care Network: A Technical Assistance Manual

Staffed Family Child Care Network Cost Estimation Tool

Metadata-only record linking to the original dataset. Open original dataset below.
Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 5 - Chicago

Source for 2012 national data: National Occupant Protection Use Survey (NOPUS), 2012. Source for 2014 national data: National Occupant Protection Use Survey (NOPUS), 2014.  Source for 2012 state data: State Observational Survey of Seat Belt Use, 2012. Source for 2014 state data: Seat Belt Use in 2014- Use Rates in the States and Territories
Compound 525183: Tetraethylene glycol, monoallyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-(2-prop-2-enoxyethoxy)ethoxy]ethoxy]ethyl acetate. Molecular Formula: C13H24O6. Molecular Weight: 276.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats

Background
          Hypertensive nephrosclerosis is the second most common cause of end-stage renal failure in the United States. The mechanism by which hypertension produces renal failure is incompletely understood. Recent evidence demonstrated that an unscheduled and inappropriate increase in apoptosis occurred in the Dahl/Rapp rat, an inbred strain of rat that uniformly develops hypertension and hypertensive nephrosclerosis; early correction of the hypertension prevents the renal injury. The present study examined the role of the Fas/FasL pathway in this process.
        
        
          Methods
          Young male Dahl/Rapp salt-sensitive (S) and Sprague-Dawley rats were fed diets that contained 0.3% or 8.0% NaCl diets. Kidneys were examined at days 7 and 21 of the study.
        
        
          Results
          An increase in Fas and FasL expression was observed in glomerular and tubular compartments of kidneys of hypertensive S rats, whereas dietary salt did not change expression of either of these molecules in normotensive Sprague-Dawley rats. Associated with this increase was cleavage of Bid and activation of caspase-8, the initiator caspase in this apoptotic pathway, by day 21 of the study.
        
        
          Conclusions
          Augmented expression of apoptotic signaling by the Fas/FasL pathway occurred during development of end-stage renal failure in this model of hypertensive nephrosclerosis.
Patent AT-E40059-T1: [Translated] METHOD AND DEVICE FOR THE MANUFACTURE OF ROTATIONAL ELEMENTS BY FLOW FORMING.

A process and machine for fabricating a rotation body having different diameters along the length thereof is disclosed, in which a blank is rotated and worked between two pressure zones to apply thereto a local pressure exceeding the flow limit of the blank material whereby circularly extending impressions of the different diameters are worked into the blank, the pressure zones crossing each other. The pressure zones are displaced relative to each other while applying the local pressure, the displacement motion having a component extending in the longitudinal direction of at least one of the pressure zones and the points of intersection of the crossing pressure zones forming a geometric line, and the blank is displaced in dependence on this line and on the different diameters to be produced.
Compound 528737: p-Octopamine, DTFMB-TBDMS

Chemical compound data from PubChem database. IUPAC Name: N-[2-[tert-butyl(dimethyl)silyl]oxy-2-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]ethyl]-3,5-bis(trifluoromethyl)benzamide. Molecular Formula: C29H41F6NO3Si2. Molecular Weight: 621.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527730: Propanoic acid, 3-bromo-2-chloro, 4-methylbutyl ester

Chemical compound data from PubChem database. IUPAC Name: 4-methylpentyl 3-bromo-2-chloropropanoate. Molecular Formula: C9H16BrClO2. Molecular Weight: 271.58. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Multi Year Medi-Cal Dental Measures Data by Age Groups Calendar Year 2013 to 2022

This dataset shows the use of Medi-Cal dental benefits by Medi-Cal members, displayed by age group and calendar year (for 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, and 2022). This information is displayed in the following categories: Continuity Care oral evaluation or a prophylaxis, Usual Source of Care, Overall Utilization of Dental Services 1 year, 2 years and 3 years. The Medi-Cal members were continuously enrolled in either Dental Managed Care or the dental Fee-for-Service delivery system for the entire measurement period.
Patent AT-E401796-T1: [Translated] SNACK FRUIT

The present invention is directed to a packaged, shelf-stable, gelled natural fruit pulp, in which the natural pectins of the fruit pulp have been substantially demethoxylated by the action of a pectinmethylesterase enzyme under ultra-high pressure (UHP) conditions. Also provided is a method of preparation of the packaged, ambient-stable, natural fruit product.
Outcome of major cardiac injuries at a Canadian trauma center

Background
          Canadian trauma units have relatively little experience with major cardiac trauma (disruption of a cardiac chamber) so injury outcome may not be comparable to that reported from other countries. We compared our outcomes to those of other centers.
        
        
          Methods
          Records of patients suffering major cardiac trauma over a nine-year period were reviewed. Factors predictive of outcome were analyzed.
        
        
          Results
          Twenty-seven patients (11 blunt and 16 penetrating) with major cardiac trauma were evaluated. Injury severity scores (ISS) were similar for blunt (49.6 ± 16.6) and penetrating (39.5 ± 21.6, p = 0.20) injuries. Five of 11 blunt trauma patients, and 9 of 16 penetrating trauma patients, had detectable vital signs on hospital arrival (p = 0.43). Ten patients underwent emergency department thoracotomy and 11 patients had cardiac repair in the operating theatre. Eleven patients survived and 16 died. Survivors had a lower ISS (33.7 ± 15.4) than non-survivors (50.4 ± 20.4; p = 0.03). Two of 11 blunt trauma patients and 9 of 16 penetrating trauma patients survived (p = 0.06). Eleven of 14 patients with detectable vital signs survived; all 13 without detectable vital signs died (p = 0.00003). Ten of eleven patients treated in the operating theatre survived, while only one of the other 16 patients survived (p = 0.00002).
        
        
          Conclusions
          Patients with major cardiac injuries and detectable vital signs on hospital arrival can be salvaged by prompt surgical intervention in the operating theatre. Major cardiac injuries are infrequently encountered at our center but patient survival is comparable to that reported from trauma units in other countries.
CFSR Technical Bulletin #11

This Technical Bulletin provides information about adjustments the Children’s Bureau (CB) is making when setting and evaluating the attainment of case review measurement goals for Program Improvement Plans (PIPs). These changes apply to the third round of the Child and Family Services Reviews (CFSRs) and amends information provided in CFSR Technical Bulletin #9, Section IIC.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 529310: 1H,1H,17H-Dotriacontafluoro-1-heptadecanol

Chemical compound data from PubChem database. IUPAC Name: 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17-dotriacontafluoroheptadecan-1-ol. Molecular Formula: C17H4F32O. Molecular Weight: 832.16. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.